Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-038827

Options or other derivatives

  • General Counsel and Secretary acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Belloff Neil S. · General Counsel and Secretary

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-06-18 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +125,000 125,000 D
Loading xslF345X03/doc4.xml…